Document is current
Any future updates will be listed below
-
Authors
Tonnus, Wulf https://orcid.org/0000-0002-9728-1413
Meyer, Claudia https://orcid.org/0000-0002-8722-0772
Steinebach, Christian https://orcid.org/0000-0001-5638-1955
Belavgeni, Alexia
von Mässenhausen, Anne
Gonzalez, Nadia Zamora
Maremonti, Francesca
Gembardt, Florian https://orcid.org/0000-0003-2739-345X
Himmerkus, Nina
Latk, Markus
Locke, Sophie
Marschner, Julian
Li, Wenjun
Short, Spencer https://orcid.org/0000-0002-6839-1568
Doll, Sebastian
Ingold, Irina
Proneth, Bettina https://orcid.org/0000-0002-4119-9437
Daniel, Christoph https://orcid.org/0000-0002-6803-4755
Kabgani, Nazanin
Kramann, Rafael
Motika, Stephen
Hergenrother, Paul J. https://orcid.org/0000-0001-9018-3581
Bornstein, Stefan R. https://orcid.org/0000-0002-5211-2536
Hugo, Christian
Becker, Jan Ulrich
Amann, Kerstin
Anders, Hans-Joachim
Kreisel, Daniel
Pratt, Derek https://orcid.org/0000-0002-7305-745X
Gütschow, Michael
Conrad, Marcus https://orcid.org/0000-0003-1140-5612
Linkermann, Andreas https://orcid.org/0000-0001-6287-9725
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (324141047)
- License Information
-
More Information
Article History
Received: 19 March 2021
Accepted: 25 June 2021
First Online: 20 July 2021
Competing interests
: A. L., C. S, and M. G issued a patent for Nec-1f with the number 20160943.5. M. C. is co-founder and shareholder of ROSCUE Therapeutics GmbH. Apart from this, all authors declare no conflict of interest regarding any of the presented data in this paper.
